Skip to main content

Books in Pharmaceutical sciences

Elsevier's Pharmaceutical Science collection helps pharmaceutical scientists striving to optimize drug design and improve healthcare outcomes by offering comprehensive coverage of every aspect of drug development, integrating disciplines like organic chemistry, biology, and biotechnology. Focused on safety, efficacy, and formulation design, it includes specialized fields such as Clinical Pharmacology and Translational Research, providing valuable insights into the latest advancements in drug discovery.

51-60 of 489 results in All results

Intelligent Nanobiosystems in Medicine and Healthcare, Volume 2

  • 1st Edition
  • December 1, 2024
  • Vijay Mishra + 2 more
  • English
  • Paperback
    9 7 8 - 0 - 3 2 3 - 9 0 2 5 4 - 0
  • eBook
    9 7 8 - 0 - 3 2 3 - 9 0 2 5 5 - 7
Intelligent Nanobiosystems in Medicine and Healthcare, Volume 2: Applications of Intelligent Nanobiosystems provides recent progress in the nanobiosystems arena, helping readers better design and develop novel drug delivery systems and devices that take advantage of recent advances in nanomedical technologies. The book explores a wide range of promising approaches for the diagnosis and treatment of diseases using the latest advancements in cutting-edge nanomedical technologies. This updated volume includes chapters by experts in the field, featuring an exploration of targeted therapy and drug delivery systems, analytical and imaging tools, theranostics, tissue engineering and regenerative medicines, dentistry tools and modern developments.This book will be a useful resource for researchers and postgraduate students in pharmaceutical sciences and biotechnology industries as well as medical professionals, biologists, chemists, materials scientists, clinical researchers, and biochemical and biomedical engineers working both in industry and academia.

Healthcare 4.0

  • 1st Edition
  • December 1, 2024
  • Atheer Awad + 1 more
  • English
  • Paperback
    9 7 8 - 0 - 4 4 3 - 1 3 7 1 9 - 8
  • eBook
    9 7 8 - 0 - 4 4 3 - 1 3 7 2 0 - 4
Healthcare 4.0: Pharmaceutical Advancement in the Digital Age is a well-structured and easy to understand book that discusses digital health technologies in context of their pharmaceutical applications and the future they hold for this sector. The contents of the book are structured in four parts, covering digital health, software technologies, hardware technologies and the outlook and impact of these innovations to pharmaceutical care. Topics covered include artificial intelligence (AI) and machine learning, blockchain, computational modelling, Telemedicine and Telepharmacy, and virtual/augmented/mixed reality and associated hardware (such as sensors, robotics, smartphones and 3D printing).This book is the perfect resources for academics and corporate researchers in pharmacy, pharmacists, physicians and pharmacy technicians to better understand and position themselves to benefit from the technological developments impacting pharma.

Fundamentals and Future Trends of 3D Printing in Drug Delivery

  • 1st Edition
  • December 1, 2024
  • Dimitrios A. Lamprou + 1 more
  • English
Fundamentals and Future Trends of 3D Printing in Drug Delivery provides readers with all needed information for their journey from ideation to approval of innovative drug delivery devices produced through additive manufacturing.This book provides an in-depth discussion on key factors affecting the printing process such as different printer technologies, materials selection, resolutions, temperatures and speeds. Dedicated chapters include specific drug delivery devices in the form of oral solid dosage, implants, catheters and vascular grafts, and microneedles. The prospects of 3D printing associated with personalized medicine are covered in a full chapter.Fundamentals and Future Trends of 3D Printing in Drug Delivery is the perfect reference for any researcher or professional embarking on a 3D printing process for drug delivery devices. The regulatory aspects included are of particular interest to companies entering this promising market.

Side Effects of Drugs Annual

  • 1st Edition
  • Volume 46
  • December 1, 2024
  • Sidhartha D. Ray
  • English
  • Hardback
    9 7 8 - 0 - 4 4 3 - 2 9 4 4 6 - 4
  • eBook
    9 7 8 - 0 - 4 4 3 - 2 9 4 4 7 - 1
Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Volume 46, first published in 1977, presents clinicians and medical investigators with a critical survey of new data and trends in adverse drug reactions and interactions. Topics covered include ADRs, ADEs and SEDs: A Bird’s Eye View, Lithium, Drugs of abuse, Side effects of drugs used in the treatment of Alzheimer's disease, Sedatives and hypnotics, Antipsychotic agents, Anti-epileptic Medications, Side effects of opioid analgesics and narcotic antagonists, Anti-inflammatory and antipyretic analgesics and drugs used in gout, Side effects of local anesthetics and therapeutic gases, and more.Other sections covered include Antihistamines (H1 receptor antagonists), Drugs that act on the respiratory tract, Positive inotropic drugs and drugs used in dysrhythmias, Beta adrenergic antagonists and antianginal drugs, Drugs acting on the cerebral and peripheral circulations, Antihypertensive drugs, and much much more.

Technological Advances and Innovations in the Treatment of Chronic Respiratory Disorders

  • 1st Edition
  • November 21, 2024
  • Gabriele De Rubis + 5 more
  • English
  • Paperback
    9 7 8 - 0 - 4 4 3 - 2 7 3 4 5 - 2
  • eBook
    9 7 8 - 0 - 4 4 3 - 2 7 3 4 4 - 5
Technological Advances and Innovations in the Treatment of Chronic Respiratory Disorders provides a comprehensive overview of the latest therapeutic and diagnostic innovations in the field, with a focus on 3D printing, bioprinting, microfluidics, organ-on-a-chip systems, and molecular modelling. The book, written by a team of leading experts in the field, is an essential resource for anyone who is interested in the future of CRD treatment. It begins by providing an overview of the economic and healthcare burden of CRDs, as well as the current treatment strategies available. The next chapters discuss the emerging therapeutic approaches for CRDs, including biologicals and phytoceuticals. The core chapters of the book then cover the application of 3D printing, bioprinting, microfluidics, organ-on-a-chip systems, and molecular modelling to the different CRDs. The book concludes with a discussion of the current clinical trials and future prospects for the management of CRDs. Technological Advances and Innovations in the Treatment of Chronic Respiratory Disorder is a valuable resource for researchers, clinicians, and other healthcare professionals who are interested in the latest technological advances in the field of CRDs. It will also be of interest to students and scientists who are working in the fields of pharmaceutical sciences, microfluidics, bioinformatics, drug design, drug delivery, and 3D printing.

Nonclinical Development of Biologics, Vaccines and Specialty Biologics

  • 2nd Edition
  • November 1, 2024
  • Lisa Plitnick + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 4 4 3 - 1 3 3 4 4 - 2
  • eBook
    9 7 8 - 0 - 4 4 3 - 1 3 3 4 5 - 9
Nonclinical Development of Biologics, Biosimilars, Vaccines and Specialty Biologics, Second Edition is a complete reference devoted to the nonclinical safety assessment of novel biopharmaceuticals, biosimilars, vaccines, cell and gene therapies, and blood products. Updated and revised, the new edition compares and contrasts these types of biologics with one another, and with small molecule drugs while incorporating the most current and essential international regulatory guidelines. Each section discusses a different type of biologic, as well as early characterization strategies, principles of study design, preclinical pharmacokinetics and pharmacodynamics and preclinical assays.This multi-edited book with chapters authored by leading qualified experts in the field offers a comprehensive reference on critical insights that will be of interest to researchers involved in early through late-stage biologics.

Theranostics Nanomaterials in Drug Delivery

  • 1st Edition
  • November 1, 2024
  • Prashant Kesharwani + 1 more
  • English
  • Paperback
    9 7 8 - 0 - 4 4 3 - 2 2 0 4 4 - 9
  • eBook
    9 7 8 - 0 - 4 4 3 - 2 2 0 4 5 - 6
Theranostics Nanomaterials in Drug Delivery presents the most recent advances in the development of theranostic nanomaterials for drug delivery. This book compiles reports and studies on the latest changes and improvements of theranostic nanocarriers such as nanoemulsions, liposomes, exosomes, polymeric micelles, PLGA nanoparticles, chitosan nanoparticles, dendrimer, quantum dots, silica nanoparticles, gold nanoparticles, silver nanoparticles, magnetic nanoparticles, and many more, all of which can help in the sensitive diagnosis, precise targeting, and efficient and controlled delivery of nanomaterials to control various diseases at different clinical stages.Theranostics nanomaterials in drug delivery will serve as a solid foundation and reference for pharmaceutical scientists, undergraduate and postgraduate students, researchers, and experts in the medical field involved in the development of advanced drug delivery systems.

Bacterial Enzymes as Targets for Drug Discovery

  • 1st Edition
  • November 1, 2024
  • Punit Kaur + 1 more
  • English
  • Paperback
    9 7 8 - 0 - 4 4 3 - 2 2 2 2 2 - 1
  • eBook
    9 7 8 - 0 - 4 4 3 - 2 2 2 2 1 - 4
Bacterial Enzymes as Targets for Drug Discovery: Meeting the Challenges of Antibiotic Resistance addresses the gap between medical microbiology, structural biology, and genomic science in the development of new antibacterial drug development. This book consolidates detailed profiling of bacterial target enzyme families for the drug discovery process and methodologies for use and validation of the potential drug targets. The content covers the foundations of antibiotic drug discovery process and focuses on bacterial enzymes as drug targets, building a bridge between microbiology, structural biology, and genomic science.This is the ideal reference for antibiotic drug discovery researchers in the pharma industry and academia. Biochemists, microbiologists, and medicinal chemists will also benefit from this books’ content.

Introduction to Pharmaceutical Technology Development

  • 1st Edition
  • November 1, 2024
  • Yaser Dahman
  • English
  • Paperback
    9 7 8 - 0 - 4 4 3 - 2 3 8 4 8 - 2
  • eBook
    9 7 8 - 0 - 4 4 3 - 2 3 8 4 9 - 9
Introduction to Pharmaceutical Technology Development: Journey from Lab to Shelf of Commercial Pharmaceutical Drugs is a complete reference and learning resource for those working in pharmaceutics or aspiring to join the industry. The book provides a comprehensive view into all aspects of drug discovery, approval, and production. Using examples of well-known drugs and their journeys from lab to market, the book provides a comprehensive overview of all steps involved in bringing new drugs, including biologics, to the shelves.Topics covered include Drug Discovery, Pharmaceutical Formulations of Different Dose Form, Analytical Testing and Development, Unit Operations and Design for Major Equipment, Basics of Analytics and Process Validations and Protocols (DQ, IQ, OQ, PQ) in FDA-Regulated Industries.This book provides graduate students from several areas with a solid foundation of the Pharmaceutic industry across key stages on new drug lifecycle.

Migraine Pain Management

  • 1st Edition
  • November 1, 2024
  • Stephen B. Shrewsbury
  • English
  • Paperback
    9 7 8 - 0 - 4 4 3 - 2 4 7 0 5 - 7
  • eBook
    9 7 8 - 0 - 4 4 3 - 2 4 7 0 4 - 0
Migraine Management: Current Pharmacological and Non-pharmacological Options is a comprehensive guide to established, recent, and ongoing pharmaceuticals and device development projects. The book provides detailed information on the historical developments of migraine pain management, druggable targets, drugs action mechanisms, drugs for acute treatment and preventive care of patients, administration routes, and alternative treatments. This is the ideal reference for academic researchers interested in anti-migraine pharmacology. It is also the perfect reference for physicians and care professionals involved in the well-being of migraine patients.